Caxton Associates LP Neogenomics Inc Transaction History

Caxton Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $342,657 - $678,033	-48,535 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $517,918 - $1.5 Million	42,627 Added 721.51%	48,535 $590,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $180,134 - $286,478	5,908 New	5,908 $202,000
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $655,908 - $807,735	-33,516 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $406,884 - $685,737	33,516 New	33,516 $686,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.